Membrane lipids and enzymes of cultured high- and low-metastatic B16 melanoma variants - PubMed (original) (raw)

PMID: 6146400

Comparative Study

Membrane lipids and enzymes of cultured high- and low-metastatic B16 melanoma variants

F Schroeder et al. Cancer Res. 1984 Aug.

Abstract

B16 melanoma cell variants were used to determine if the metastatic properties of these cells could be correlated to distinct plasma membrane, microsome, and mitochondrial membrane lipid compositions and membrane-bound enzyme activities in high- and low-metastatic cell variants, respectively. The high-metastatic B16-F10 melanoma cell membranes had lower cholesterol/phospholipid ratios, lower arachidonic acid content, lower polyunsaturated fatty acid content, higher phosphatidylcholine/phosphatidylethanolamine ratios, and higher succinate cytochrome c reductase activity than those of B16-F1 melanoma cell membranes. No differences in cholesterol/phospholipid ratio were noted in the mitochondria. Na+-K+-adenosinetriphosphatase activity and solubility of 5'-nucleotidase activity were also similar. The data indicate that the membrane lipid composition of B16-F10 melanoma cells is distinct from that of B16-F1 melanoma cells and may help to elucidate the molecular basis for the different metastatic properties of these cell lines in vivo.

PubMed Disclaimer

Cited by

Abnormal lipid and fatty acid compositions of kidneys from mice with polycystic kidney disease.
Aukema HM, Yamaguchi T, Takahashi H, Celi B, Holub BJ. Aukema HM, et al. Lipids. 1992 Jun;27(6):429-35. doi: 10.1007/BF02536384. Lipids. 1992. PMID: 1385849
A UHPLC-Mass Spectrometry View of Human Melanocytic Cells Uncovers Potential Lipid Biomarkers of Melanoma.
Perez-Valle A, Abad-García B, Fresnedo O, Barreda-Gómez G, Aspichueta P, Asumendi A, Astigarraga E, Fernández JA, Boyano MD, Ochoa B. Perez-Valle A, et al. Int J Mol Sci. 2021 Nov 8;22(21):12061. doi: 10.3390/ijms222112061. Int J Mol Sci. 2021. PMID: 34769491 Free PMC article.
Higher cell stiffness indicating lower metastatic potential in B16 melanoma cell variants and in (-)-epigallocatechin gallate-treated cells.
Watanabe T, Kuramochi H, Takahashi A, Imai K, Katsuta N, Nakayama T, Fujiki H, Suganuma M. Watanabe T, et al. J Cancer Res Clin Oncol. 2012 May;138(5):859-66. doi: 10.1007/s00432-012-1159-5. J Cancer Res Clin Oncol. 2012. PMID: 22297840
Targeted Metabolomics Identifies Plasma Biomarkers in Mice with Metabolically Heterogeneous Melanoma Xenografts.
Weber DD, Thapa M, Aminzadeh-Gohari S, Redtenbacher AS, Catalano L, Feichtinger RG, Koelblinger P, Dallmann G, Emberger M, Kofler B, Lang R. Weber DD, et al. Cancers (Basel). 2021 Jan 23;13(3):434. doi: 10.3390/cancers13030434. Cancers (Basel). 2021. PMID: 33498757 Free PMC article.
Evaluation of the metastatic potential of malignant cells by image processing of digital holographic microscopy data.
Calin VL, Mihailescu M, Scarlat EI, Baluta AV, Calin D, Kovacs E, Savopol T, Moisescu MG. Calin VL, et al. FEBS Open Bio. 2017 Sep 2;7(10):1527-1538. doi: 10.1002/2211-5463.12282. eCollection 2017 Oct. FEBS Open Bio. 2017. PMID: 28979841 Free PMC article.

Membrane lipids and enzymes of cultured high- and low-metastatic B16 melanoma variants - PubMed (original) (raw)